Please select the option that best describes you:

What modifications, if any, will you make for your use of dose dense taxane chemotherapy in early stage breast cancer with the end-of-study PANTHER results?  

Does this trial change whether you'd utilize weekly or biweekly taxane regimens, or which taxane you'd use?